Search Results

DD DuPont de Nemours, Inc. - Fundamental Analysis

BULLISH
DD Stock | Fundamental Analysis & Investment Insights
NYSE Basic Materials Specialty Chemicals
Current Price
$39.71
Analyst Target
$53.25
+34.1% Upside
52W High
$41.23
52W Low
$22.5

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Nov 16, 2025
Market cap
$17.01B
P/E
22.95
ROE
3.2%
Profit margin
-6.0%
Debt/Equity
0.4
Dividend yield
3.6%

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
88%
Analysis Accuracy
DuPont (DD) presents a compelling value opportunity despite near-term earnings volatility, trading at a steep discount to peers on forward earnings while demonstrating consistent top-line growth and strong operating leverage. The stock has outperformed materially over the past 6 months (+38.5%) and 1 year (+16.6%), reflecting improving sentiment ahead of earnings recovery. A robust 3.6% dividend yield, disciplined capital structure with low debt/equity (0.40), and a strong history of earnings beat rates (22 of 25 quarters) bolster investor confidence. However, negative net income margin (-6.01%) and elevated payout ratio (93%) warrant caution, though the forward P/E of 9.05 suggests significant earnings inflection is priced in.

Key Strengths

Forward P/E of 9.05 is deeply discounted vs sector average (32.65) and peers like ECL (37.15) and SHW (32.47)
Consistent revenue growth of 7.3% YoY, outpacing sector average of 5.88% and peers LIN (3.1%) and SHW (3.2%)
Strong operating margin of 17.77%, indicating pricing power and cost discipline despite macro headwinds
Impressive earnings beat streak: 22 of last 25 quarters beat estimates, with average surprise of +11.5% over the last 12 quarters
Attractive dividend yield of 3.6%, well above sector average and peer group (APD: ~3.0%, ECL: ~1.2%, SHW: ~1.8%, LIN: ~1.5%)

Key Risks

Negative profit margin of -6.01% raises concerns about near-term profitability, likely driven by restructuring or one-time charges
High dividend payout ratio of 93.06% threatens sustainability if earnings do not recover as expected
Insider selling activity totaling $5.71M in the last 6 months, including CTO sales, signals internal caution
Liquidity risk highlighted by low quick ratio of 0.84, below the current ratio of 2.00, suggesting inventory overhang
EV/EBITDA and cash flow metrics unavailable, limiting full assessment of leverage and cash generation capacity
AI Fair Value Estimate
Based on comprehensive analysis
$53.25
+34.1% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
80
Strong
Value
92
Future
80
Past
83
Health
75
Dividend
68
AI Verdict
DuPont scores highly on value and future earnings recovery potential, supported by strong operating margins and a deep valuation discount to peers, while recent price momentum and analyst target of $53.25 imply 34% upside. Despite negative net margins and insider selling, the company's historical execution, resilient revenue growth, and solid balance sheet position it well for a cyclical rebound.
Key drivers: Deeply undervalued on forward P/E (9.05) vs sector (32.65), Consistent top-line growth and operating margin strength, Analyst target implies significant upside with strong buy consensus
Confidence
88%
Value
92/100

DuPont trades at a steep discount to peers on forward earnings—ECL (37.15), SHW (32.47), LIN (28.32)—and the sector average (32.65), suggesting either mispricing or embedded skepticism about margin recovery.

Positives
  • Forward P/E of 9.05 offers substantial discount to sector average of 32.65
  • Price/Book of 0.73 indicates shares trade below book value, rare in specialty chemicals
Watchpoints
  • Lack of EV/EBITDA and PEG data limits comprehensive valuation view
  • Negative earnings complicate P/E interpretation despite forward optimism
Future
80/100

Despite recent EPS contraction, the 7.3% revenue growth and strong analyst target of $53.25 suggest confidence in a turnaround, supported by positive price momentum (+38.5% over 6M).

Positives
  • Revenue growth of 7.3% YoY exceeds peer and sector averages
  • Forward P/E of 9.05 implies strong earnings rebound is expected in 2025-2026
Watchpoints
  • Most recent YoY EPS growth is -7.6%, indicating near-term headwinds persist
  • Q/Q EPS declined -2.7%, suggesting momentum has stalled
Past
83/100

DuPont has a strong track record of beating earnings expectations and delivering long-term shareholder returns (+64.7% over 5Y), but recent profitability collapse and weak ROE signal operational stress despite solid historical execution.

Positives
  • 22 of last 25 quarters beat EPS estimates, with average surprise of +11.5%
  • 5-year return of +64.7% reflects long-term value creation despite volatility
Watchpoints
  • Profit margin turned negative (-6.01%), breaking a trend of profitability
  • ROE of 3.22% lags far behind sector average of 24.47% and peers like SHW (59.94%)
Health
75/100

DuPont maintains a conservative capital structure with low leverage relative to peers and the sector, but the weak quick ratio and missing cash/debt data raise questions about near-term liquidity flexibility.

Positives
  • Debt/Equity of 0.40 is conservative vs sector average of 1.50 and peers like SHW (3.25)
  • Current ratio of 2.00 indicates adequate short-term solvency
Watchpoints
  • Quick ratio of 0.84 suggests potential liquidity strain if inventories cannot be liquidated
  • Total cash and debt figures unavailable, limiting full solvency assessment
Dividend
68/100

The 3.6% yield is a key investor draw, but the 93% payout ratio—on negative earnings—raises red flags about long-term sustainability, particularly if earnings recovery is delayed.

Positives
  • 3.6% dividend yield is attractive in a low-yield environment and exceeds peer average
  • Dividend has been maintained despite earnings volatility, indicating policy discipline
Watchpoints
  • Payout ratio of 93.06% is dangerously high, especially with negative net income
  • No data on 5-year yield trend or dividend growth history limits sustainability assessment

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$39.71
Analyst Target
$53.25
Upside/Downside
+34.1%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for DD and closest competitors.

Updated 2025-11-14
Company 5Y 3Y 1Y 6M 1M 1W
DD
DuPont de Nemours, Inc.
Primary
+64.7% +42.6% +16.6% +38.5% +20.9% -0.2%
CTVA
Corteva, Inc.
Peer
+85.9% +2.0% +16.1% -3.3% +6.6% +2.9%
APD
Air Products and Chemicals, Inc.
Peer
+9.9% -5.1% -15.8% -5.8% +0.8% -0.1%
ECL
Ecolab Inc.
Peer
+27.9% +75.0% +5.5% +0.3% -5.5% +1.0%
SHW
The Sherwin-Williams Company
Peer
+42.4% +42.2% -13.6% -8.2% +0.1% -2.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
22.95
Forward P/E
9.05
PEG Ratio
N/A
P/B Ratio
0.73
P/S Ratio
1.32
EV/Revenue
1.9
EV/EBITDA
7.44
Market Cap
$17.01B

Profitability

Profit margins and return metrics

Profit Margin -6.01%
Operating Margin 17.77%
Gross Margin 37.12%
ROE 3.22%
ROA 3.46%

Growth

Revenue and earnings growth rates

Revenue Growth +7.3%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.4
Low debt
Current Ratio
2.0
Strong
Quick Ratio
0.84
Poor
Cash/Share
$4.67

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-10
$N/A
2025-11-06
$1.09
+11.2% surprise
2025-08-05
$1.12
+5.5% surprise
2025-05-02
$1.03
+8.1% surprise

Basic Materials Sector Comparison

Comparing DD against 6 companies in the Basic Materials sector (2 bullish, 4 neutral, 0 bearish)
P/E Ratio
22.95
This Stock
vs
29.52
Sector Avg
-22.3% (Discount)
Return on Equity (ROE)
3.22%
This Stock
vs
17.96%
Sector Avg
-82.1% (Below Avg)
Profit Margin
-6.01%
This Stock
vs
7.43%
Sector Avg
-180.8% (Weaker)
Debt to Equity
0.4
This Stock
vs
1.09
Sector Avg
-63.7% (Less Debt)
Revenue Growth
7.3%
This Stock
vs
7.23%
Sector Avg
+0.9% (Growing)
Current Ratio
2.0
This Stock
vs
1.38
Sector Avg
+44.7% (Stronger)

Similar Companies

Peer comparison within the same industry

Company AI Rating Market Cap P/E ROE Profit Margin Price
DD
DuPont de Nemours, Inc.
BULLISH $17.01B 22.95 3.2% -6.0% $39.71
CTVA
Corteva, Inc.
NEUTRAL $44.73B 26.72 6.7% 9.2% $66.0
APD
Air Products and Chemicals, Inc.
NEUTRAL $58.54B - -1.9% -3.3% $259.34
ECL
Ecolab Inc.
NEUTRAL $74.2B 37.15 21.9% 12.5% $258.58
SHW
The Sherwin-Williams Company
NEUTRAL $84.0B 32.47 59.9% 11.0% $332.18

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date Insider Position Transaction Shares Value
2025-10-31 HOOVER ERIK THOMAS General Counsel Stock Award 23,079 -
2025-10-31 LARRABEE STEVEN P Chief Technology Officer Stock Award 13,078 -
2025-10-31 KOCH LORI Chief Executive Officer Stock Award 98,613 -
2025-10-31 RAIA CHRISTOPHER Officer Stock Award 19,232 -
2025-10-31 FRANZEN ANTONELLA B Chief Financial Officer Stock Award 20,755 -
2025-10-31 BREEN EDWARD D. Officer and Director Stock Award 192,332 -
2025-09-15 LARRABEE STEVEN P Chief Technology Officer Sale 43,208 $3,334,386
2025-09-15 LARRABEE STEVEN P Chief Technology Officer Option Exercise 39,208 $2,419,578
2025-09-05 LARRABEE STEVEN P Chief Technology Officer Sale 31,000 $2,380,500
2025-09-04 LARRABEE STEVEN P Chief Technology Officer Option Exercise 25,000 $1,651,500
2025-08-29 LOWERY FREDERICK M. Director Stock Award 503 $38,750
2025-08-29 CUTLER ALEXANDER M Director Stock Award 650 $50,000
2025-08-29 CURTIN TERRENCE R Director Stock Award 422 $32,500
2025-08-29 BRADY AMY G Director Stock Award 105 $8,125
2025-08-20 BREEN EDWARD D. Officer and Director Gift 28,111 -
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
16 analysts
Wells Fargo
2025-11-07
Maintains
Overweight Overweight
UBS
2025-11-07
Maintains
Buy Buy
Keybanc
2025-11-07
Maintains
Overweight Overweight
UBS
2025-11-05
Maintains
Buy Buy
Keybanc
2025-11-05
Maintains
Overweight Overweight
BMO Capital
2025-11-03
Maintains
Outperform Outperform
JP Morgan
2025-10-15
Maintains
Overweight Overweight
BMO Capital
2025-09-19
Maintains
Outperform Outperform
RBC Capital
2025-09-19
reit
Outperform Outperform
RBC Capital
2025-08-08
Maintains
Outperform Outperform